Edition:
United Kingdom

Ono Pharmaceutical Co Ltd (4528.T)

4528.T on Tokyo Stock Exchange

2,708JPY
2:14am GMT
Change (% chg)

¥20 (+0.74%)
Prev Close
¥2,688
Open
¥2,680
Day's High
¥2,717
Day's Low
¥2,675
Volume
1,024,700
Avg. Vol
2,309,277
52-wk High
¥2,734
52-wk Low
¥2,185

Select another date:

Thu, Dec 14 2017

BRIEF-Ono Pharmaceutical enters into license agreement with Bristol-Myers Squibb for Prostaglandin E2 receptor antagonists

* Says it entered into license agreement with Bristol-Myers Squibb Company (BMS)for Prostaglandin E2 receptor antagonists relating to Immuno-Oncology programs

BRIEF-Bristol-Myers Squibb Granted Exclusive License By Ono Pharmaceutical For Multiple Programs Targeting Immuno-Suppressive Factors In The Tumor Microenvironment

* BRISTOL-MYERS SQUIBB GRANTED EXCLUSIVE LICENSE BY ONO PHARMACEUTICAL FOR MULTIPLE PROGRAMS TARGETING IMMUNO-SUPPRESSIVE FACTORS IN THE TUMOR MICROENVIRONMENT

BRIEF-Ono Pharmaceutical completes retirement of treasury shares

* Says it completed retirement of 45.9 million shares (7.8 percent of outstanding) on Oct. 31

BRIEF-Karyopharm and Ono Pharmaceutical sign exclusive license agreement to develop and commercialize Selinexor and KPT-8602 in Japan and other countries in Asia

* Karyopharm and Ono Pharmaceutical Co. Ltd. sign exclusive license agreement to develop and commercialize Selinexor and KPT-8602 in Japan and other countries in Asia

BRIEF- Ono Pharmaceutical completes share repurchase

* Says it completes repurchase of 15.9 million shares of its common stock, for 38.77 billion yen in total, from June 14 to Sept. 29

BRIEF-Array Biopharma reports Q4 loss per share $0.17

* Array Biopharma reports financial results for the fourth quarter and full year of fiscal 2017

BRIEF-OncoTherapy Science says close of peptide vaccine related agreement with ONO PHARMACEUTICAL

* Says peptide vaccine related agreement with ONO PHARMACEUTICAL CO., LTD. will close on Sept. 4

Select another date: